Literature DB >> 22591179

Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children.

R-P Janapatla1, M-H Hsu, Y-C Hsieh, H-Y Lee, T-Y Lin, C-H Chiu.   

Abstract

Streptococcus pneumoniae infection is a leading cause of morbidity and mortality worldwide. One of the most severe complications of invasive pneumococcal disease (IPD) is haemolytic uraemic syndrome (HUS). This study was undertaken to determine the risk factors and role of pneumococcal neuraminidases in HUS in children with IPD. Eighteen cases of HUS and 54 patients with IPD without HUS were identified. The controls were patients with culture-confirmed IPD without HUS. Clinical and laboratory characteristics of the two groups of patients were compared. Bacterial isolates from both groups were serotyped, sequence typed and examined for their carriage of three neuraminidase genes. Necrotizing pneumonia and serotype 3 infection were significantly associated with HUS in children with IPD, suggesting that a severe pulmonary suppurating disease increase the risk of HUS. Serotype 14 was associated with necrotizing pneumonia but not HUS. Children with HUS were more likely to require surgery and had a longer duration of hospitalization. The study identified a significantly higher carriage of a neuraminidase gene, nanC, in the causative pneumococcal isolates from patients with HUS (89% versus 41%, p 0.001). The sensitivity and specificity of nanC to predict HUS were 89% and 59%, respectively. In conclusion, necrotizing pneumonia, serotype 3 infection and neuraminidase gene nanC were associated with HUS in children with IPD. The result suggests that NanC could provide an additive effect to NanA and NanB in the overall activity of pneumococcal neuraminidases to expose Thomsen-Friedenreich antigen on various cells in patients with HUS.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591179     DOI: 10.1111/j.1469-0691.2012.03894.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

1.  Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors.

Authors:  An Xiao; Teri J Slack; Yanhong Li; Dashuang Shi; Hai Yu; Wanqing Li; Yang Liu; Xi Chen
Journal:  J Org Chem       Date:  2018-08-23       Impact factor: 4.354

Review 2.  Pneumococcal disease and use of pneumococcal vaccines in Taiwan.

Authors:  Sung-Hsi Wei; Chuen-Sheue Chiang; Chyi-Liang Chen; Cheng-Hsun Chiu
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

3.  Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit.

Authors:  Hsiang-Ju Hsiao; Chang-Teng Wu; Jing-Long Huang; Cheng-Hsun Chiu; Yhu-Chering Huang; Jainn-Jim Lin; I-Anne Huang; Oi-Wa Chan; I-Jun Chou; Shao-Hsuan Hsia
Journal:  BMC Pediatr       Date:  2015-07-17       Impact factor: 2.125

4.  Streptococcus pneumoniae NanC: STRUCTURAL INSIGHTS INTO THE SPECIFICITY AND MECHANISM OF A SIALIDASE THAT PRODUCES A SIALIDASE INHIBITOR.

Authors:  C David Owen; Petra Lukacik; Jane A Potter; Olivia Sleator; Garry L Taylor; Martin A Walsh
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

Review 5.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

Authors:  M A Fletcher; H-J Schmitt; M Syrochkina; G Sylvester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-23       Impact factor: 3.267

6.  Evolutionary inactivation of a sialidase in group B Streptococcus.

Authors:  Masaya Yamaguchi; Yujiro Hirose; Masanobu Nakata; Satoshi Uchiyama; Yuka Yamaguchi; Kana Goto; Tomoko Sumitomo; Amanda L Lewis; Shigetada Kawabata; Victor Nizet
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

Review 7.  Necrotizing pneumonia: an emerging problem in children?

Authors:  I Brent Masters; Alan F Isles; Keith Grimwood
Journal:  Pneumonia (Nathan)       Date:  2017-07-25

Review 8.  Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine.

Authors:  Hemant S Agarwal; Samir Q Latifi
Journal:  Pathogens       Date:  2021-06-09

9.  Low Serum Fetuin-A as a Biomarker to Predict Pneumococcal Necrotizing Pneumonia and Hemolytic Uremic Syndrome in Children.

Authors:  Rajendra Prasad Janapatla; Mei-Hua Hsu; Wan-Ting Liao; Kun-Yi Chien; Hao-Yuan Lee; Cheng-Hsun Chiu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Assessing the function of pneumococcal neuraminidases NanA, NanB and NanC in in vitro and in vivo lung infection models using monoclonal antibodies.

Authors:  Philipp Janesch; Harald Rouha; Adriana Badarau; Lukas Stulik; Irina Mirkina; Marisa Caccamo; Katharina Havlicek; Barbara Maierhofer; Susanne Weber; Karin Groß; Jacqueline Steinhäuser; Manuel Zerbs; Cecilia Varga; Ivana Dolezilkova; Sabine Maier; Gerhild Zauner; Nels Nielson; Christine A Power; Eszter Nagy
Journal:  Virulence       Date:  2018       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.